CDK4とCDK6キナーゼ:基礎科学からがん治療へ
Anne Fassl1, Yan Geng1, Piotr Sicinski1
1Department of Cancer Biology, Dana-Farber Cancer Institute, Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215, USA.
Science (New York, N.Y.)
|January 13, 2022
まとめ
サイクリン依存キナーゼ4/6 (CDK4/ 6) 阻害剤は効果的ながん治療法である. 新興の研究では,これらの阻害剤は腫瘍細胞の代謝と免疫にも影響を及ぼし,より広範な治療の可能性を示唆しています.
科学分野:
- 腫瘍学
- 分子生物学
- 細胞サイクル規制
背景:
- サイクリン依存キナーゼ4と6 (CDK4/ 6) とD型サイクリンが細胞サイクル進行を調節する.
- サイクリンDCDK4/ 6の構成的活性化は,複数の癌の主要な要因である.
- CDK4/ 6阻害剤は,ホルモン受容体陽性乳がんの治療法として確立されています.
研究 の 目的:
- 細胞サイクル制御を超えたCDK4/6の生物学に関する最近の発見をレビューする.
- 腫瘍細胞の代謝と免疫に対するCDK4/ 6抑制の影響を調査する.
- 癌治療におけるCDK4/6阻害剤の新たな治療戦略について議論する.
主な方法:
- CDK4/ 6阻害剤に関する最近の研究の文献レビュー.
- CDK4/6抑制によって影響された細胞機能に関するデータの分析.
- 新興の治療応用に関する情報の統合
主要な成果:
- CDK4/ 6の抑制は腫瘍細胞の代謝に影響する.
- CDK4/ 6抑制は抗腫瘍免疫を調節する.
- これらの効果は,CDK4/ 6阻害剤の役割の拡大を示唆する.
結論:
- 最近の進歩により,CDK4/6の生物学に関する理解が深まった.
- CDK4/ 6阻害剤は,既定の指示を超えて有望であることが示されています.
- 腫瘍学におけるCDK4/6阻害剤の利用に関する新しい治療法が開発されています.
さらに関連する動画
11:11Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
7.6K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.5K
関連する概念動画
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
02:34Inhibition of Cdk Activity
5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
02:39Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:38Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K